| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.57B | $1.44B | $1.42B |
| YoY Revenue Growth % | +9.1% | +0.9% | — |
| Gross Profit | $363.9M | $339.4M | — |
| Gross Margin % | 23.2% | 23.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $194.2M | $191.3M | $547.3M |
| Operating Margin % | 12.4% | 13.3% | 38.5% |
| Net Income (GAAP) | $220.5M | $207.9M | $518.5M |
| EBITDA (Normalized) | $549.7M | $540.2M | $598.5M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $395.5M | $448.7M | $676.6M |
| Capital Expenditures (CapEx) | $444.4M | $436.2M | $64.0M |
| Free Cash Flow (FCF) | -$48.9M | $12.5M | $612.5M |
| FCF Margin % | -3.1% | 0.9% | 43.1% |
| Return on Invested Capital (ROIC %) | 5.4% | 6.0% | 6.1% |
| Cash & Short-Term Equivalents | $235.4M | $271.9M | — |
| Total Debt (Short + Long Term) | $133.4M | $132.4M | $2.73B |
| Total Stockholders' Equity | $2.92B | $2.65B | $5.61B |